West Pharmaceutical Services (WST) Payables (2009 - 2026)

West Pharmaceutical Services has disclosed Payables across 18 years of filings, most recently posting $252.7 million for Q2 2026.

• In Q2 2026, Payables rose 5.73% year-over-year to $252.7 million; the TTM figure through Jun 2026 stood at $252.7 million (up 5.73% YoY), while the FY2025 annual figure was $253.7 million, up 6.02% from the prior year.
• Payables came in at $252.7 million for Q2 2026 at West Pharmaceutical Services, roughly flat from $252.3 million in the prior quarter.
• In the past five years, Payables ranged from a high of $376.4 million in Q4 2023 to a low of $188.9 million in Q3 2022.
• Average Payables over 5 years is $263.0 million, with a median of $252.5 million recorded in 2026.
• Year-over-year, Payables soared 72.98% in 2023 and tumbled 38.85% in 2025.
• Over 5 years, Payables stood at $217.6 million in 2022, then soared by 72.98% to $376.4 million in 2023, then slumped by 36.42% to $239.3 million in 2024, then rose by 6.02% to $253.7 million in 2025, then slipped by 0.39% to $252.7 million in 2026.
• Per Business Quant data, the three most recent Payables figures were $252.7 million in Q2 2026, $252.3 million in Q1 2026, and $253.7 million in Q4 2025.